Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
2012 · Ophthalmology · 2,415 citations
https://doi.org/10.1016/j.ophtha.2012.09.006
J
Jean‐François Korobelnik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
468
Papers
16.2K
Citations
55
h-index
156
i10-index
Jean‐François Korobelnik is an academic researcher from Université de Bordeaux. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal Imaging and Analysis & Retinal and Optic Conditions. The author has an h-index of 55, co-authored 398 publications.
ORCID: 0000-0002-4438-9535Papers by this author
worksPrevalence of Age-Related Macular Degeneration in Europe
2017 · Ophthalmology · 474 citations
https://doi.org/10.1016/j.ophtha.2017.05.035
Prevalence of Age-Related Macular Degeneration in Europe
2017 · Ophthalmology · 474 citations
https://doi.org/10.1016/j.ophtha.2017.05.035
Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium
2015 · European Journal of Epidemiology · 438 citations
https://doi.org/10.1007/s10654-015-0010-0
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES
2015 · Retina · 278 citations
https://doi.org/10.1097/iae.0000000000000627
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
2024 · The Lancet · 179 citations
https://doi.org/10.1016/s0140-6736(24)00063-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat